These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10353388)

  • 1. Chemically induced preneoplastic lesions in rodents as indicators of carcinogenic activity.
    Williams GM
    IARC Sci Publ; 1999; (146):185-202. PubMed ID: 10353388
    [No Abstract]   [Full Text] [Related]  

  • 2. Medium-term bioassays in rats for rapid detection of the carcinogenic potential of chemicals.
    Shirai T; Hirose M; Ito N
    IARC Sci Publ; 1999; (146):251-72. PubMed ID: 10353390
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of non-mammalian species in bioassays for carcinogenicity.
    Bunton TE
    IARC Sci Publ; 1999; (146):151-84. PubMed ID: 10353387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual documentation of neoplasms as part of the REGISTRY Nomenclature Information System.
    Morawietz G; Rittinghausen S; Mohr U
    Zentralbl Pathol; 1992 Dec; 138(6):431-4. PubMed ID: 1297438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinogenic chemical-response "fingerprint" for male F344 rats exposed to a series of 195 chemicals: implications for predicting carcinogens with transgenic models.
    Johnson FM
    Environ Mol Mutagen; 1999; 34(4):234-45. PubMed ID: 10618171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioassays for carcinogenicity in animals. Early preneoplastic lesions.
    Bannasch P; Griesemer RA; Anders F; Becker R; Cabral JR; Della Porta G; Feron VJ; Henschler D; Ito N; Kroes R
    IARC Sci Publ; 1986; (83):85-101. PubMed ID: 3305354
    [No Abstract]   [Full Text] [Related]  

  • 7. Ageing and the mechanisms of carcinogenesis: some practical implications.
    Anisimov VN
    J Exp Clin Cancer Res; 1998 Sep; 17(3):263-8. PubMed ID: 9894760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of hepatic preneoplastic lesions as indicators of carcinogenic response.
    Bannasch P; Zerban H
    IARC Sci Publ; 1992; (116):389-427. PubMed ID: 1428091
    [No Abstract]   [Full Text] [Related]  

  • 9. An enhanced thirteen-week bioassay as an alternative for screening for carcinogenesis factors.
    Cohen SM
    Asian Pac J Cancer Prev; 2010; 11(1):15-7. PubMed ID: 20593920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonistic interactions of an arsenic-containing mixture in a multiple organ carcinogenicity bioassay.
    Pott WA; Benjamin SA; Yang RS
    Cancer Lett; 1998 Nov; 133(2):185-90. PubMed ID: 10072168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-and medium-term carcinogenicity tests: simple initiation-promotion assay systems.
    Tsuda H; Park CB; Moore MA
    IARC Sci Publ; 1999; (146):203-49. PubMed ID: 10353389
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolution of the uses of rats and mice for assessing carcinogenic risk from chemicals in humans.
    Ward JM
    Asian Pac J Cancer Prev; 2010; 11(1):18. PubMed ID: 20593921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic properties of preneoplastic rat liver lesions and applications to detection of carcinogens and tumor promoters.
    Williams GM
    Toxicol Pathol; 1998; 26(3):452-3. PubMed ID: 9608653
    [No Abstract]   [Full Text] [Related]  

  • 14. Highlights of International meeting on Alternative Methods of Carcinogenicity Testing, Leesburg, VA, November 1-3, 2000, Sponsored by the Health and Environmental Sciences Institute.
    Jollow DJ
    J Agromedicine; 2004; 9(2):427-9. PubMed ID: 19785235
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential staining of dysplastic aberrant crypt foci in the colon facilitates prediction of carcinogenic potentials of chemicals in rats.
    Ochiai M; Watanabe M; Nakanishi M; Taguchi A; Sugimura T; Nakagama H
    Cancer Lett; 2005 Mar; 220(1):67-74. PubMed ID: 15737689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically altered mouse models for identifying carcinogens.
    Tennant RW; Stasiewicz S; Mennear J; French JE; Spalding JW
    IARC Sci Publ; 1999; (146):123-50. PubMed ID: 10353386
    [No Abstract]   [Full Text] [Related]  

  • 17. [Criteria, rules and procedures adopted by IARC in evaluating risks from different carcinogenic agents for humans].
    IARC
    Vopr Onkol; 2007; 53(6):621-41. PubMed ID: 18416130
    [No Abstract]   [Full Text] [Related]  

  • 18. Society of toxicologic pathology position on assessment of hyperplastic lesions in rodent carcinogenicity studies.
    Boorman G; Dixon D; Elwell M; Kerlin R; Morton D; Peters T; Regan K; Sullivan J;
    Toxicol Pathol; 2004; 32(1):124-5. PubMed ID: 14713557
    [No Abstract]   [Full Text] [Related]  

  • 19. Thresholds in carcinogenicity in ED01 study.
    Rozman KK
    Toxicol Sci; 2003 Sep; 75(1):224-5. PubMed ID: 12923303
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of cell transformation systems for carcinogenicity testing and mechanistic studies of carcinogenesis.
    Barrett JC; Hesterberg TW; Thomassen DG
    Pharmacol Rev; 1984 Jun; 36(2 Suppl):53S-70S. PubMed ID: 6473503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.